{
    "id": "9122369",
    "text": "Anatumomab mafenatox is a mouse monoclonal antibody studied for the treatment non-small cell lung cancer, which acts as a tumor-targeted superantigen. It is a fusion protein of a human tumor-associated 5T4 antigen monoclonal IgG1 Fab fragment with an enterotoxin ('mafenatox') of Staphylococcus aureus. Development was abandoned in 2005.http://adisinsight.springer.com/drugs/800013422 ==References== Category:Monoclonal antibodies for tumors Category:Abandoned drugs ",
    "title": "Anatumomab mafenatox"
}